US · Healthcare

Castle Biosciences Inc (CSTL)

Diagnostics & Research

Castle Biosciences Inc (CSTL) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CSTL

P/E ratio

18.00

Castle Biosciences Inc (CSTL) — FAQ

What is CSTL's P/E ratio?

The price-to-earnings (P/E) ratio for Castle Biosciences Inc (CSTL) is 18.00 (data as of 2026-03-24).

Does Castle Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Castle Biosciences Inc (CSTL). Check the MyAverix Finance app for the latest dividend data.

What sector is Castle Biosciences Inc in?

Castle Biosciences Inc (CSTL) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is CSTL listed on?

CSTL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)